Overexpression of CDC25C in acral melanoma

被引：0
|
作者：
Bahrami, A. [1 ]
Mawad, J. [1 ]
Krishnan, B. [2 ]
Reed, J. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Houston, TX USA
来源：
JOURNAL OF CUTANEOUS PATHOLOGY | 2008年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [31] CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma
    Zhou, Chaoting
    Wang, Luyang
    Hu, Wanye
    Tang, Lusheng
    Zhang, Ping
    Gao, Yan
    Du, Jing
    Li, Yanchun
    Wang, Ying
    BIOENGINEERED, 2022, 13 (05) : 13089 - 13107
  • [32] Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data
    Xia, Zengfei
    Wen Ou-yang
    Hu, Ting
    Du, Ketao
    CANCER GENETICS, 2019, 233 : 67 - 74
  • [33] Recurrent CDC25C mutations drive malignant transformation in FPD/AML
    Yoshimi, Akihide
    Toya, Takashi
    Kawazu, Masahito
    Ueno, Toshihide
    Tsukamoto, Ayato
    Iizuka, Hiromitsu
    Nakagawa, Masahiro
    Nannya, Yasuhito
    Arai, Shunya
    Ichikawa, Motoshi
    Harada, Hironori
    Usuki, Kensuke
    Hayashi, Yasuhide
    Ito, Etsuro
    Kirito, Keita
    Nakajima, Hideaki
    Mano, Hiroyuki
    Kurokawa, Mineo
    CANCER RESEARCH, 2014, 74 (19)
  • [34] Cdc25C interacts with PCNA at G2/M transition
    Kawabe, T
    Suganuma, M
    Ando, T
    Kimura, M
    Hori, H
    Okamoto, T
    ONCOGENE, 2002, 21 (11) : 1717 - 1726
  • [35] Recurrent CDC25C mutations drive malignant transformation in FPD/AML
    Akihide Yoshimi
    Takashi Toya
    Masahito Kawazu
    Toshihide Ueno
    Ayato Tsukamoto
    Hiromitsu Iizuka
    Masahiro Nakagawa
    Yasuhito Nannya
    Shunya Arai
    Hironori Harada
    Kensuke Usuki
    Yasuhide Hayashi
    Etsuro Ito
    Keita Kirito
    Hideaki Nakajima
    Motoshi Ichikawa
    Hiroyuki Mano
    Mineo Kurokawa
    Nature Communications, 5
  • [36] DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms:: One involves direct binding to the cdc25C promoter
    St Clair, S
    Giono, L
    Varmeh-Ziaie, S
    Resnick-Silverman, L
    Liu, WJ
    Padi, A
    Dastidar, J
    DaCosta, A
    Mattia, M
    Manfredi, JJ
    MOLECULAR CELL, 2004, 16 (05) : 725 - 736
  • [37] Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery
    BaoZhong Li
    ZhaoLi Chen
    SuSheng Shi
    XiaoLi Feng
    XiaoGang Tan
    Fang Zhou
    Jie He
    Chinese Journal of Cancer, 2013, 32 (07) : 403 - 409
  • [38] Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery
    Li, Bao-Zhong
    Chen, Zhao-Li
    Shi, Su-Sheng
    Feng, Xiao-Li
    Tan, Xiao-Gang
    Zhou, Fang
    He, Jie
    CHINESE JOURNAL OF CANCER, 2013, 32 (07) : 403 - 409
  • [39] In vivo structure of the cell cycle-regulated human cdc25C promoter
    Körner, K
    Müller, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (25) : 18676 - 18681
  • [40] Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases
    Ferguson, AM
    White, LS
    Donovan, PJ
    Piwnica-Worms, H
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (07) : 2853 - 2860
12345